Skip to main content
Clinical Trials/IRCT20180416039326N19
IRCT20180416039326N19
Completed
Phase 3

Comparison of safety and efficacy of two doses of Dexmedetomidine in reducing the incidence of cough after endotracheal tube removal in a patient undergoing elective surgery

Esfahan University of Medical Sciences0 sites540 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Tracheal Extubation.
Sponsor
Esfahan University of Medical Sciences
Enrollment
540
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients who are candidates for elective surgery
  • Age range is 18\-60 years and with ASA class 1 and 2\.
  • Patient consent to participate in the study

Exclusion Criteria

  • History of allergy to Alpha adrenergic drugs
  • Liver patients
  • Patients with a history of Bradycardia
  • Vascular problems
  • Hypotension
  • Vasodilator use
  • Hypovolemia
  • People who are at risk for increased intracranial pressure or intraocular pressure
  • Addicted people or Smokers
  • People with asthma

Outcomes

Primary Outcomes

Not specified

Similar Trials